151 related articles for article (PubMed ID: 11355694)
1. Up-Regulation of ninjurin expression in human hepatocellular carcinoma associated with cirrhosis and chronic viral hepatitis.
Kim JW; Moon AR; Kim JH; Yoon SY; Oh GT; Choe YK; Choe IS
Mol Cells; 2001 Apr; 11(2):151-7. PubMed ID: 11355694
[TBL] [Abstract][Full Text] [Related]
2. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.
Jiang J; Gusev Y; Aderca I; Mettler TA; Nagorney DM; Brackett DJ; Roberts LR; Schmittgen TD
Clin Cancer Res; 2008 Jan; 14(2):419-27. PubMed ID: 18223217
[TBL] [Abstract][Full Text] [Related]
3. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma.
Chung YH; Kim JA; Song BC; Lee GC; Koh MS; Lee YS; Lee SG; Suh DJ
Cancer; 2000 Sep; 89(5):977-82. PubMed ID: 10964327
[TBL] [Abstract][Full Text] [Related]
6. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.
Li G; Cai G; Li D; Yin W
Postgrad Med J; 2014 Feb; 90(1060):106-12. PubMed ID: 24243965
[TBL] [Abstract][Full Text] [Related]
8. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
[TBL] [Abstract][Full Text] [Related]
10. [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma].
Xie YM; Li X; Yan LN; Wei B; Wang CH; Tang CW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):710-6. PubMed ID: 26619541
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.
Chen GG; Lai PB; Chak EC; Xu H; Lee KM; Lau WY
Cancer Lett; 2001 Oct; 172(1):75-82. PubMed ID: 11595132
[TBL] [Abstract][Full Text] [Related]
12. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis.
Mamiya T; Yamazaki K; Masugi Y; Mori T; Effendi K; Du W; Hibi T; Tanabe M; Ueda M; Takayama T; Sakamoto M
Lab Invest; 2010 Sep; 90(9):1339-45. PubMed ID: 20531292
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
Park BC; Huh MH; Seo JH
J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
[TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
15. The expression of P21 and P15 proteins in liver tissue of chronic viral hepatitis and hepatocellular carcinoma and their relation to cell apoptosis.
Wang Y; Wang L; Wang S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):157-9. PubMed ID: 11503050
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
[TBL] [Abstract][Full Text] [Related]
17. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Kwon SH; Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY
Clin Mol Hepatol; 2012 Sep; 18(3):287-94. PubMed ID: 23091809
[TBL] [Abstract][Full Text] [Related]
19. Amplification of BCR protein associated with oncogenesis in human hepatocellular carcinoma.
Miyazaki Y; Mitsuma T; Ichida T; Odazima H; Ishihara K; Asakura H
Dig Dis Sci; 1997 May; 42(5):927-37. PubMed ID: 9149044
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
